Authors:
Shaddy, RE
Lambert, LM
Fuller, TC
Profaizer, T
Thompson, DD
Baker, SI
Osborne, KA
Hawkins, JA
Citation: Re. Shaddy et al., Prospective randomized trial of azathioprine in cryopreserved valved allografts in children, ANN THORAC, 71(1), 2001, pp. 43-47
Authors:
Hawkins, JA
Breinholt, JP
Lambert, LM
Fuller, TC
Profaizer, T
McGough, EC
Shaddy, RE
Citation: Ja. Hawkins et al., Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients, J THOR SURG, 119(2), 2000, pp. 324-328
Authors:
Breinholt, JP
Hawkins, JA
Lambert, LM
Fuller, TC
Profaizer, T
Shaddy, RE
Citation: Jp. Breinholt et al., A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery, CIRCULATION, 102(19), 2000, pp. 179-182
Authors:
Stringham, JC
Bull, DA
Fuller, TC
Kfoury, AG
Taylor, DO
Renlund, DG
Karwande, SV
Citation: Jc. Stringham et al., Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization, J HEART LUN, 18(2), 1999, pp. 160-165
Authors:
Fuller, A
Profaizer, T
Roberts, L
Fuller, TC
Citation: A. Fuller et al., Repeat donor HLA-DR mismatches in renal transplantation: Is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?, TRANSPLANT, 68(4), 1999, pp. 589-591
Citation: Tc. Fuller et A. Fuller, The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder, TRANSPLANT, 68(2), 1999, pp. 173-182